Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT04408885
Recruiting Observational

Rehabilitation Treatment of Anterior Cruciate Ligament Rupture

NCT04408885 · tracked via the Priya Life Science Denmark tracker
Sponsor
Aarhus University Hospital
Phase
Observational
Started
2020-08-15
Last updated
2025-10-01

Condition(s) studied

ACL Injury

Investigational drug(s) / intervention(s)

Rehabilitation

Rehabilitation: Non-surgical interventions to patients with an Anterior cruciate ligament injury. Rehabilitation regime is the regime provided by the physician at the rehabilitation clinic.

Study summary

The purpose with this present study is to investigate the effect og a non-surgical regime in patients with an Anterior Cruciate ligament injury.

The effect will be measured by patient reported outcome scores, level of function and how many of the patients are converting to operative treatment.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: * Anterior cruciate ligament injury where rehabilitation regime is selected as treatment. Exclusion Criteria: * Other knee ligament instability * Rheumatoid arthritis * Morbus Bechterews Disease

Primary outcome measure(s)

  • Changes in patient reported outcome score (IKDC) — Baseline - 2 Years
    The International Knee Documentation Committee (0-100)

Trial sites (1)

FacilityCityRegionStatus
Division of Sports Trauma, Palle Juul-Jensens Boulevard 99 Aarhus N Denmark Recruiting

More Aarhus University Hospital trials in Denmark

Body Project SMIL: Prevention of Eating Disorders Among Young Women With Psychiatric Illness With the Body Project Starting soon
Assessment of Residual Congestion in Acute Decompensated Heart Failure Recruiting
Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke Recruiting
Progressive Resistance Training for Adults With External Snapping Hip Recruiting
Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal Cancer Recruiting

Other trials for the same condition

The Faroese Knee Cohort: Etiology and Long-term Implications of Trochlear Dysplasia and Patellar Dislocations. Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04408885 on ClinicalTrials.gov ↗ ← All trials in Denmark